Onco Therapeutics
Published 4 issues per year
ISSN Print: 2694-4642
ISSN Online: 2694-4650
Indexed in
Volume 1, 2010 Issue 3
DOI: 10.1615/ForumImmunDisTher.v1.i3
Cross-Regulation Between WNT and NF-κB Signaling Pathways
pp. 155-181
DOI: 10.1615/ForumImmunDisTher.v1.i3.10
Inducible Nitric Oxide Synthase/ Cyclooxygenase-2 Pathway Interaction: A Good Molecular Target for Cancer Treatment
pp. 183-204
DOI: 10.1615/ForumImmunDisTher.v1.i3.20
Broad-Spectrum Anti-Cancer Activity of O2-Arylated Diazeniumdiolates
pp. 205-218
DOI: 10.1615/ForumImmunDisTher.v1.i3.30
Inhibition of Snail-induced Epithelial-Mesenchymal Transition and Induction of the Tumor Metastasis Suppressor Gene Raf-1 Kinase Inhibitor Protein (RKIP) by DETANONOate
pp. 219-230
DOI: 10.1615/ForumImmunDisTher.v1.i3.40
Latest Issue
Preface: Phytochemicals for Colorectal Cancer Therapy
Novel and Latest Computational and Development of Anticancer Cancer
Isoquinoline Alkaloids: Promising Natural Compounds for Targeting Angiogenesis and Metastasis in Colon Cancer
Naringenin in the Prevention of Colon Cancer: An Updated Review
Anti-Cancer Pectins and Their Role in Colorectal Cancer Treatment
Citrus Flavones Luteolin and Apigenin Target Fundamental Mechanisms in Colon Cancer
Dietary Phytocompounds for Colon Cancer Therapy
Nano-Formulation for Curcumin and Resveratrol in Colorectal Cancer Therapy